• A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis.
  Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, Kaner RJ, Olman MA,
  PubMed:22561965 :: 2012

• Erdheim chester disease: an unusual fluid overload mimic.
  Joshi M, Olman M
  PubMed:22298365 :: 2012

• Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity.
  Wang D, Olman MA, Stewart J, Tipps R, Huang P, Sanders PW, Toline E, Prayson RA, Lee J, Weil RJ, Palmer CA, Gillespie GY, Liu WM, Pieper RO, Guan JL, Gladson CL
  PubMed:21602932 :: 2011

• Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts.
  Cai GQ, Zheng A, Tang Q, White ES, Chou CF, Gladson CL, Olman MA, Ding Q
  PubMed:20109444 :: 2010

• Beyond TGF-beta: a prostaglandin promotes fibrosis.
  Olman MA
  PubMed:19966771 :: 1996

• Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins.
  Zhu S, Gladson CL, White KE, Ding Q, Stewart J, Jin TH, Chapman HA, Olman MA
  PubMed:19411312 :: 2009

• CXCL12-mediated induction of plasminogen activator inhibitor-1 expression in human CXCR4 positive astroglioma cells.
  Oh JW, Olman M, Benveniste EN
  PubMed:19336886 :: 2009

• Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner.
  Ding Q, Gladson CL, Wu H, Hayasaka H, Olman MA
  PubMed:18669633 :: 2008

• Prostaglandin E2 mediates IL-1beta-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors.
  White KE, Ding Q, Moore BB, Peters-Golden M, Ware LB, Matthay MA, Olman MA
  PubMed:18097066 :: 2008

• Muscle fatigue: MK2 signaling and myofibroblast differentiation.
  Hagood JS, Olman MA
  PubMed:17940320 :: 2007

• Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
  Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Khanna D, Li N, Li G,
  PubMed:17717203 :: 2007

• Acute exacerbations of idiopathic pulmonary fibrosis.
  Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE, Lasky JA, Loyd JE, Noth I, Olman MA, Raghu G, Roman J, Ryu JH, Zisman DA, Hunninghake GW, Colby TV, Egan JJ, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kondoh Y, Lynch DA, Müller-Quernheim J, Myers JL, Nicholson AG, Selman M, Toews GB, Wells AU, Martinez FJ,
  PubMed:17585107 :: 2007

• Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
  Khanna D, Yan X, Tashkin DP, Furst DE, Elashoff R, Roth MD, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Clements PJ,
  PubMed:17469162 :: 2007

• Biologic markers of mortality in acute lung injury.
  Gaggar A, Olman MA
  PubMed:16797514 :: 2006

• Cyclophosphamide versus placebo in scleroderma lung disease.
  Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M,
  PubMed:16790698 :: 2006

• Epithelium, heal thyself!
  Olman MA
  PubMed:16411381 :: 2005

• Glutathione restores collagen degradation in TGF-beta-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen.
  Vayalil PK, Olman M, Murphy-Ullrich JE, Postlethwait EM, Liu RM
  PubMed:16258002 :: 2005

• Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1 beta-induced IL-6 expression.
  Olman MA, White KE, Ware LB, Simmons WL, Benveniste EN, Zhu S, Pugin J, Matthay MA
  PubMed:14764742 :: 2004

• Glutathione regulates transforming growth factor-beta-stimulated collagen production in fibroblasts.
  Liu RM, Liu Y, Forman HJ, Olman M, Tarpey MM
  PubMed:12959930 :: 2004

• Transforming growth factor-beta induces fibrosis in immune cell-depleted lungs.
  Olman MA, Matthay MA
  PubMed:12902316 :: 2003

• The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged.
  Ding Q, Stewart J, Olman MA, Klobe MR, Gladson CL
  PubMed:12881526 :: 2003

• Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.
  Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA
  PubMed:12730079 :: 2003

• Epithelial cell modulation of airway fibrosis in asthma.
  Olman MA
  PubMed:12540477 :: 2003

• Microarray analysis indicates that pulmonary edema fluid from patients with acute lung injury mediates inflammation, mitogen gene expression, and fibroblast proliferation through bioactive interleukin-1.
  Olman MA, White KE, Ware LB, Cross MT, Zhu S, Matthay MA
  PubMed:11893691 :: 2002

• Adenovirally mediated expression of urokinase receptor binding site on integrin alpha-chain blocks adhesion and migration of human lung fibroblasts.
  Zhu S, Gladson CL, Stewart J, White KE, Chapman HA, Olman MA
  PubMed:11893675 :: 2002

• Modulating the fibrinolytic system of peripheral blood mononuclear cells with adenovirus.
  Schleef RR, Olman MA, Miles LA, Chuang JL
  PubMed:11242535 :: 2001

• Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages.
  Horton MR, Olman MA, Bao C, White KE, Choi AM, Chin BY, Noble PW, Lowenstein CJ
  PubMed:11000131 :: 2000

• Attachment of primary neonatal rat astrocytes to vitronectin is mediated by integrins alphavbeta5 and alpha8beta1: modulation by the type 1 plasminogen activator inhibitor.
  Gladson CL, Stewart JE, Olman MA, Chang PL, Schnapp LM, Grammer JR, Benveniste EN
  PubMed:10739899 :: 2000

• Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element.
  Olman MA, Hagood JS, Simmons WL, Fuller GM, Vinson C, White KE
  PubMed:10477732 :: 1999

• Fibrin fragment response elements in the plasminogen activator inhibitor gene.
  Olman MA, Hagood JS, Simmons WL, White KE
  PubMed:10424630 :: 1999

• Hyaluronan fragments induce plasminogen activator inhibitor-1 and inhibit urokinase activity in mouse alveolar macrophages: a potential mechanism for impaired fibrinolytic activity in acute lung injury.
  Horton MR, Olman MA, Noble PW
  PubMed:10424564 :: 1999

• Facile purification of fibrinogen fragments using a computer-based model with general applicability to the generation of salt gradients.
  Olman MA, Williams WF, Strickland JH, Hagood JS, Simmons WL, Rivera KE
  PubMed:9758753 :: 1998

• Pulmonary arterial hypertension: dipping into the reserve.
  Olman MA
  PubMed:9631771 :: 1998

• Adenovirally mediated gene transfer of functional human tissue-type plasminogen activator to murine lungs.
  Simmons WL, Rivera KE, Curiel DT, Williams WF, Olman MA
  PubMed:9490648 :: 1998

• Polymerization of fibrinogen in murine bleomycin-induced lung injury.
  Olman MA, Simmons WL, Pollman DJ, Loftis AY, Bini A, Miller EJ, Fuller GM, Rivera KE
  PubMed:8897898 :: 1996

• Regulation of type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts.
  Hagood JS, Olman MA, Godoy JA, Rivera KE, Fuller GM
  PubMed:8611700 :: 1996

• Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
  Olman MA, Mackman N, Gladson CL, Moser KM, Loskutoff DJ
  PubMed:7544811 :: 1995

• Increased expression and activity of sodium channels in alveolar type II cells of hyperoxic rats.
  Yue G, Russell WJ, Benos DJ, Jackson RM, Olman MA, Matalon S
  PubMed:7667305 :: 1995

• Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.
  Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ
  PubMed:7747809 :: 1995

• Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli.
  Lang IM, Marsh JJ, Olman MA, Moser KM, Schleef RR
  PubMed:8044939 :: 1994

• Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli.
  Lang IM, Marsh JJ, Olman MA, Moser KM, Loskutoff DJ, Schleef RR
  PubMed:8205686 :: 1994

• Effect of chronic thromboembolism on the pulmonary artery pressure-flow relationship in dogs.
  Olman MA, Gan RZ, Yen RT, Villespin I, Maxwell R, Pedersen C, Konopka R, Debes J, Moser KM
  PubMed:8175602 :: 1994

• Factors contributing to increased vascular fibrinolytic activity in mongrel dogs.
  Lang IM, Marsh JJ, Konopka RG, Olman MA, Binder BR, Moser KM, Schleef RR
  PubMed:8504514 :: 1990

• Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
  Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR
  PubMed:1394930 :: 1992

• Pulmonary vascular steal in chronic thromboembolic pulmonary hypertension.
  Olman MA, Auger WR, Fedullo PF, Moser KM
  PubMed:2245685 :: 1990

Cai GQ, Zheng A, Tang Q, White ES, Chou CF, Gladson CL, Olman MA, Ding Q. Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts. Exp Cell Res. 2010 Jan 25.

Olman MA. Beyond TGF-beta: a prostaglandin promotes fibrosis. Nat Med. 2009 Dec;15(12):1360-1.

Raghu G; IPFnet. Improving the standard of care for patients with idiopathic pulmonary fibrosis requires participation in clinical trials. Chest. 2009 Aug;136(2):330-3.

J De Andrade and M.A. Olman. Coagulation and Fibrinolysis in Lung Injury and Repair. M. Schwarz and T. King, Ed., In: Interstitial Lung Disease 5th Edition Dekker, London, UK (In Press).

S Zhu, CL Gladson, KE White, Q Ding, J Stewart, Jr., T Jin, HA Chapman, Jr, and M. A. Olman. Urokinase receptor mediates lung fibroblast attachment and migration towards provisional matrix proteins through interactions with multiple integrins. Am J of Physiol LCMP 2009; 297:L97-L108 (Journal Cover Figure) PDF

Q Ding, CL Gladson, H Wu, H Haysaka and MA Olman. FAK-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner. J Biol Chem 2008; 283:26839-49 White, KE, Ding, Q, Moore B. Peters-Golden, M, Ware LB, Matthay MA, and M.A. Olman. Prostaglandin E2 mediates IL-1β-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors. J of Immunology 180 (1): 637-646; 2008

DP Tashkin, M.D., R Elashoff, Ph.D., PJ Clements, M.D., M.P.H., et al… MA Olman, M.D., et al …THE SCLERODERMA LUNG STUDY: Oral Cyclophosphamide versus Placebo for the Treatment of Scleroderma-Related Interstitial Lung Disease. New England Journal of Medicine 354:2655-2666; 2006